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Objectives: To evaluate which indirect method for assessing adherence best reflects highly 
active antiretroviral therapy (HAART) effectiveness and the factors related to adherence.
Method: This descriptive, cross-sectional study was performed in 2012 at a reference center 
of the state of São Paulo. Self-report (simplified medication adherence questionnaire [SMAQ]) 
and drug refill parameters were compared to the viral load (clinical parameter of the effective-
ness of pharmacotherapy [EP]) to evaluate the EP. The “Cuestionario para la Evaluación de la 
Adhesión al Tratamiento Antiretroviral” (CEAT-VIH) was used to evaluate factors related to 
adherence and the EP and, complementarily, patient self-perception of adherence was compared 
to the clinical parameter of the EP.
Results: Seventy-five patients were interviewed, 60 of whom were considered as adherent 
from the clinical parameter of the EP and ten were considered as adherent from all parameters. 
Patient self-perception about adherence was the instrument that best reflected the EP when 
compared to the standardized self-report questionnaire (SMAQ) and drug refill parameter. The 
level of education and the level of knowledge on HAART were positively correlated to the EP. 
Forgetfulness, alcohol use, and lack of knowledge about the medications were the factors most 
frequently reported as a cause of nonadherence.
Conclusion: A new parameter of patient self-perception of adherence, which is a noninvasive, 
inexpensive instrument, could be applied and assessed as easily as self-report (SMAQ) during 
monthly drug refill, since it allows monitoring adherence through pharmaceutical assistance. 
Therefore, patient adherence to HAART could be evaluated using self-perception (CEAT-VIH) 
and the viral load test.
Keywords: health literacy, anti-HIV agents, patient compliance, antiretroviral therapy, highly 
active, acquired immunodeficiency syndrome
Introduction
Since its introduction in 1996, the highly active antiretroviral therapy (HAART) has 
decreased the morbidity and mortality due to the acquired immunodeficiency syndrome 
(AIDS).1 However, the maximum effectiveness of the treatment is ensured not only 
by effective and potent drugs, but also by patient adherence to the therapy.
Poor adherence is a remarkable problem as it increases the chance of virologic 
failure, decreasing the recovery of CD4 cells, increasing viral load and, therefore, 
increasing the risk of death. Another important consequence is the increased possibility 
of mutations resistant to currently available drugs.2
Factors related to poor adherence comprise treatment, health care service, patient, 
and lifestyle characteristics. Treatment characteristics include inflexible dosing 
schedules, adverse events, long periods of treatment (over 6 years), and the con-
comitant use of other drugs in addition to antiretroviral drugs. Among health care 
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service characteristics are the impaired access to health 
care services, which makes it difficult for the patient to be 
followed by a health care professional; and smaller services 
with small staff numbers, which have shown difficulties in 
standardizing and supervising the performance of health care 
professionals, as well as promoting technical discussions.3 
Forgetfulness, missing medical appointments, demotivation, 
and the educational level of the patient are also associated 
with poor adherence. Factors related to the lifestyle are the 
use of alcohol and injectable drugs, travels, social isolation, 
depression, and stress, among others.4–8
According to Bartlett,9 an adherence $95% is required 
for viral suppression; however, 40%–60% of patients 
adhere ,90% in Brazil, tending to decrease over time.3 
Nevertheless, it has been shown that a moderate adherence 
(,95%) to more powerful regimens, such as protease inhibi-
tors (PI) and non-nucleoside reverse transcriptase inhibitors, 
does not significantly affect a decreased viral load,10,11 and 
the potential to develop mutations is lower in schemes con-
taining PI.2
It is recommended assessing adherence to pharmaco-
therapy by two methods,12 which may be direct (monitoring 
plasma concentration of the drug or its metabolites), that 
tend to be more accurate, but expensive; or indirect (self-
reporting through questionnaires, pill counting, drug refill), 
and cheaper, but require more time to apply and tend to be 
less accurate. The viral load is one of the most valuable 
measures for evaluating disease progression and anti-HIV 
treatment effectiveness.13
Considering that adherence to therapy is an important 
part of the treatment and that monitoring patient adherence is 
essential to ensure the maximum effectiveness of the pharma-
cotherapy, it is important to verify whether the inexpensive 
methods truly reflect viral suppression and which patient-
related factors may influence the effectiveness. Therefore, 
this study aimed to: 1) evaluate which indirect method for 
assessing adherence best reflects HAART effectiveness, 
and 2) which sociodemographic variables and factors are 
related to adherence and the effectiveness of pharmaco-
therapy (EP).
Materials and methods
This descriptive, cross-sectional study was conducted in 2012 
at the Special Health Care Service of Araraquara, responsible 
for sexually transmitted infections/AIDS program in the city 
of Araraquara, Sao Paulo State, Brazil. Patients .18 years 
who used HAART and had a medical appointment scheduled 
in the period of the study were included. Patients who died 
during the study were excluded.
Two indirect methods for assessing adherence to 
pharmacotherapy were evaluated: drug refill and self-report 
according to the “simplified medication adherence ques-
tionnaire” (SMAQ).14 This SMAQ includes the following 
questions:
1. Do you ever forget to take your medications?
2. Do you always take your medications at the time 
indicated?
3. Do you ever stop taking the medication when you 
feel bad?
4. Did you forget to take your medication during the 
weekend?
5. In the last week, how many times did you not take a 
dose?
6. In the last 3 months, how many full days did you not take 
the medication?
These two methods were compared with the clinical param-
eter of the EP, defined as a viral load of ,400 copies/mL.
To evaluate factors and sociodemographic variables 
related to adherence and the EP, the Brazilian adapted version 
of the “Cuestionario para la Evaluación de la Adhesión al 
Tratamiento Antiretroviral” (CEAT-VIH) was used.15 This 
questionnaire assesses not only patients’ satisfaction, difficul-
ties, information, and conception about their therapy, but also 
their self-perception of adherence. Therefore, complementa-
rily, patient self-perception of adherence was also compared 
to the clinical parameter of the EP.
Data were collected on one individual interview con-
ducted after the patient’s medical appointment. The data 
collection instrument was a structured form, previously 
applied to four patients for adequacy, that contained ques-
tions including: I – patient characteristics (initials, marital 
status, sex, date of birth, and education level); II – evaluation 
of patient adherence to therapy (self-report), according to 
SMAQ; III – current pharmacotherapy; and IV – evaluation 
of patient self-perception of adherence, as well as of factors 
related to poor adherence based on CEAT-VIH.
Viral load data from the last 6 months and drug refill 
data from the last 3 months were collected using the Drug 
Logistics Control System (SICLOM).
Patients were considered adherent according to the fol-
lowing parameters:
•	 Viral load (clinical parameter of the EP): the patient 
had ,400 copies/mL or had decreased the viral load by 
one-third from the last count.16
•	 Self-report parameter using SMAQ: the patient responded 
negatively to questions 1, 3, and 4, and missed doses less 
than two times in the last week and ,2 complete days in 
the last 3 months.14
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•	 Drug refill parameter: the patient delayed monthly drug 
refill by not .2 days.16
For statistical analyses, we used the StatPlus® (AnalystSoft, 
Walnut, CA, USA) and Statistica® (StaSoft Inc., Tulsa, OK, 
USA) softwares to apply the chi-square test (95% confidence 
interval), to identify factors and sociodemographic variables 
that influence pharmacotherapy effectiveness and verify 
which method for assessing adherence is mostly correlated to 
the EP. When the expected frequencies were ,5, we applied 
the Yates correction.
The project was approved by the Research Ethics Com-
mittee of the Federal University of São Paulo/Hospital São 
Paulo (No 1365/09). All patients signed an informed consent 
before participating in this study.
Results
In the period of the study, 455 patients were registered in 
the service: only 98 of them met the inclusion criteria; 75 
(76.5%) of these agreed to participate in the interview and 
23 declined their consent. Fourteen of these were considered 
nonadherent from all parameters, 65 were considered non-
adherent from at least one of the parameters and only ten 
were considered adherent from all parameters (Figure 1). 
The sociodemographic characteristics of the patients are 
described in Table 1.
Patients deemed nonadherent from self-report parameter 
(52) were asked about the reasons for not taking drugs properly. 
Forgetfulness (26) and alcohol use (12) were the most fre-
quently reported reasons for nonadherence, followed by the 
lack of drugs (eight), travels (four), and malaise (four). As 
strategies to remember to take the medicine, patients reported 
using alarms, daily pill separators, and caregivers’ support.
From the responses to CEAT-VIH questionnaire, it was 
found that most patients believed having less or sufficient 
information about their drugs and properly following treat-
ment requires a lot of effort (Table 2). As for self-perception 
according to CEAT-VIH, 58 patients considered themselves 
as fairly adherent, which strongly corresponds to the number 
of patients deemed adherent from the clinical parameter of the 
EP (viral load) (Figure 1); on the other hand, less than half 
were considered adherent from self-report (SMAQ) and drug 
refill parameters, compared to the clinical parameter.
As difficulties to adhere to treatment, patients reported 
the complexity of the pharmacotherapy, drug size, drug taste, 
the amount of drugs, and the dosing schedule.
The association between factors or sociodemographic 
variables and the EP was statistically tested, and only the 
level of education (P=0.003) and the information that the 
patient believes to have about HAART (P=0.009) showed 
to be correlated. The therapeutic regimen (P=0.994) and 
the number of tablets administered daily (P=0.282) did 
not show any statistically significant relationship with 
the EP (Table 1).
Discussion
Though indirect methods for assessing adherence are recom-
mended for controlling and evaluating adherence to HAART 
by the sexually transmitted infections/AIDS programs of Phar-
maceutical Assistance,17 our data showed that there were differ-
ences in results depending on the instrument used (Figure 1).
Among the indirect methods used in this study, the viral 
load is the method that best reflects the EP.13,17 Nevertheless, 
it is more invasive and expensive, requires laboratory exams, 
and should be performed at least twice a year according to 
guidelines.17
It is recommended to use two methods for assessing the 
effectiveness of pharmacotherapy.12 The first method could 
be the viral load, which is the most effective for evaluating 
Adherent
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Figure 1 Patients considered adherent and nonadherent to HAART according to SMAQ, drug refill and viral load parameters (N=75).
Note: aIt was not possible to evaluate three patients using drug refill parameter.
Abbreviations: HAART, highly active antiretroviral therapy; SMAQ, simplified medication adherence questionnaire.
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the EP. The second method should be as efficient as the viral 
load and allow evaluation of adherence in an inexpensive, 
easy-to-apply, less invasive way; it should also allow to be 
applied with a higher frequency, for example during monthly 
drug refill. This second method could be the self-report using 
SMAQ or drug refill.
However, the self-report parameter has been shown 
to be too strict, since, according to Shuter et al10 and 
Bangsberg,11 an adherence of ,95% may not have a signifi-
cant impact on the viral load when potent regimens, such as 
PI and non-nucleoside reverse transcriptase inhibitors, are 
used. Only one patient in our study did not use one of these 
regimens. Therefore, this method may be excessively rigor-
ous for detecting nonadherence to HAART.
Drug refill parameter also underestimated the EP, prob-
ably because it was equally stringent. This parameter con-
siders that a delay of .2 days in monthly drug refill already 
reflects nonadherence; however, the time to refill depends 
on the amount of dispensed units and also on the days of 
operation of the service. Furthermore, the lack of policies and 
incentives for drug fractionation prevents this method from 
being effective and to directly reflect adherence.18
On the other hand, patient self-perception, evaluated using 
CEAT-VIH, was the instrument that best reflected the EP when 
compared to drug refill and self-report (SMAQ) parameters. 
Differently from self-report, patient self-perception does 
not depend on a quantitative memory, but on a qualitative 
memory: patients classify how adherent they believe they 
are without needing to remember specific events, which may 
become a more precise assessment parameter.15
Besides, CEAT-VIH not only allows patients to evalu-
ate and rethink about their adherence, but also allows health 
Table 1 Distribution of patients by sociodemographic variables and 
correlation with the effectiveness of pharmacotherapy, Araraquara – 
são Paulo, Brazil, 2010 (n=75)
Sociodemographic  
variables
n Effectiveness of  
pharmacotherapy
P-value
sex
Male 54 44 0.61
Female 21 16
Age (years)
18–24 1 1 0.28
25–34 2 2
35–44 32 22
45–54 29 25
.55 11 10
Marital status
single 26 20 0.997
stable relationship 13 13
Married 16 12
Divorced 10 7
Widower 10 8
Education (years)
0–4 16 12 0.003a
5–8 (basic education) 29 22
9–11 (high school) 18 15
.11 3 3
not informed 9 8
Note: aP,0.05.
Table 2 Analysis of factors that possibly influence adherence and correlation with the effectiveness of pharmacotherapy, Araraquara, 
sao Paulo state, Brazil, 2010 (n=75)
Factors that possibly influence adherence Effectiveness of  
pharmacotherapy
P-value
Not satisfied Indifferent Satisfied
satisfaction with treatment 4 2 69 0.904
Much Moderate None
Difficulty of taking the medication 5 5 65 0.283
None Little Moderate Much
Effort to properly follow treatment 0 24 13 38 0.593
information patient believes to have about the medication 0 29 24 22 0.009a
Information about the benefit that the use of HAART  
can bring to health
0 4 7 64 0.954
improvements in health after starting hAArT 0 11 4 60 0.305
Ability to continue with treatment 0 2 1 72 0.865
None Little Moderate Considerable Much
Intensity of the side effects of HAART 48 13 8 1 5 0.539
Time spent taking the medication 71 2 0 0 2 0.878
Evaluation of adherence to therapy 1 1 15 50 8 0.694
Note: aP,0.05.
Abbreviation: HAART, highly active antiretroviral therapy.
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care professionals to identify other factors possibly related to 
poor adherence, such as drug-related problems and adverse 
events.15 This way, health care professionals become capable 
of proposing interventions even before investigating the 
EP by clinical parameters. Evaluating adherence is impor-
tant since asymptomatic patients do not believe in the risk 
of nonadherence and tend to take their medication less 
regularly.19
Although monitoring adherence by patient self-perception 
may be time-consuming, as it depends on interviews and 
patient availability, it may be performed during the health 
counseling by multidisciplinary teams. Health counseling, an 
interactive, two-way process that starts from patient EP and 
allows identifying the reasons for nonadherence, can improve 
patient knowledge about the therapy and the consequences 
of nonadherence; therefore, the patient will be more willing 
to adhere.19,20
In our study, a correlation between EP and the level of 
education was observed. Previous studies confirmed the 
relationship between literacy and adherence,21,22 and dem-
onstrated that more educated patients have a higher chance 
to reach viral suppression than those with no or low literacy. 
This is because subjects with low literacy may have difficul-
ties in understanding the guidance provided by health care 
professionals and, therefore, will not sufficiently adhere 
to treatment.23 Health literacy indicates the ability with 
which patients receive, process, and understand informa-
tion necessary to their treatment. HIV+ patients with low 
health literacy generally present with low knowledge and 
understanding about their health condition, lower percep-
tion about the treatment, low adherence to medications and 
decreased immune function, and tend to be three times less 
adherent than those with more knowledge and understand-
ing about HAART.24,25
Therefore, data on this study suggest that a new param-
eter of patient self-perception of adherence to pharmaco-
therapy, a noninvasive, cheap instrument, could be applied 
and assessed as easily as the self-report (SMAQ) parameter 
during monthly drug refill. This way, it allows monitoring 
adherence through pharmaceutical assistance, even before 
medical visits and routine laboratory tests, and making 
interventions in order to improve adherence.
As observed in the systematic review and meta-analysis 
of Conn et al,26 interventions to improve adherence increase 
significantly patient knowledge about medications, which 
improves their quality of life, physical ability, and symp-
toms. Other interventions, such as treatment simplifica-
tion, also have a positive impact on morbidity and reduce 
treatment costs with human resources, since professionals 
are efficiently allocated.27 Analyses on the economic impact 
of the interventions to improve adherence also showed 
a significant decrease in costs for medical appointments 
and hospitalizations, though this aspect still needs further 
investigation.28,29
Concerning factors related to nonadherence, in our study, 
the reasons mainly reported in CEAT-VIH were the need 
of much effort to comply with the pharmacotherapy and 
the lack of knowledge about medications, which showed 
a significant correlation with the parameter of EP. Also, 
according to the responses to SMAQ, the mostly reported 
reason was forgetfulness.
These factors are probably related: a penta-continental 
study carried out by Nachega et al23 showed that 43% of 
patients admit to have forgotten at least one dose in the 
last month, suggesting that they possibly do not completely 
understand the impact of forgetting to take medications on 
their health. It shows that the lack of information regarding 
the risks of not using the medications prescribed can cause 
nonadherence and corroborates the results of our study. 
Educational interventions and pharmacotherapy management 
could also contribute to solve this problem.26
Conclusion
The EP was best reflected by the patient’s self-perception, 
when compared to the standardized self-report questionnaire 
(SMAQ) and drug refill.
The level of education and of knowledge on HAART 
reported by the patient are positively correlated to the EP.
Most patients feel very satisfied and capable of follow-
ing treatment, although they reported making a great effort 
to follow treatment properly, and recognize the benefits 
HAART can bring to their health and the improvements they 
have after beginning the therapy.
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